Evidence map›Paper›PMID 28282868›Full record

ArticleInternational journal of molecular sciences2017

A Pronounced Inflammatory Activity Characterizes the Early Fracture Healing Phase in Immunologically Restricted Patients.

Paula Hoff, Timo Gaber, Cindy Strehl, Manuela Jakstadt, Holger Hoff, Katharina Schmidt-Bleek, Annemarie Lang, Eric Röhner, Dörte Huscher, Georg Matziolis and 5 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Polytrauma impairs fracture healing accompanied by increased persistence of innate inflammatory stimuli and reduced adaptive response.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2025
    Article
  8. Review
  9. Review
  10. The local and systemic effects of immune function on fracture healing.OTA international : the open access journal of orthopaedic trauma · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Smoking Alters Inflammation and Skeletal Stem and Progenitor Cell Activity During Fracture Healing in Different Murine Strains.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Paula HoffDepartment of Rheumatology and Clinical Immunology, Charité University Hospital, 10117 Berlin, Germany. paula.hoff@charite.de.
Timo GaberDepartment of Rheumatology and Clinical Immunology, Charité University Hospital, 10117 Berlin, Germany. gaber@drfz.de.
Cindy StrehlDepartment of Rheumatology and Clinical Immunology, Charité University Hospital, 10117 Berlin, Germany. strehl@drfz.de.
Manuela JakstadtDepartment of Rheumatology and Clinical Immunology, Charité University Hospital, 10117 Berlin, Germany. jakstadt@drfz.de.
Holger HoffGerman Rheumatism Research Center (DRFZ), 10117 Berlin, Germany. holger.hoff@icloud.com.
Katharina Schmidt-BleekJulius Wolff Institute, Charité University Hospital, 13353 Berlin, Germany. katharina.schmidt-bleek@charite.de.
Annemarie LangDepartment of Rheumatology and Clinical Immunology, Charité University Hospital, 10117 Berlin, Germany. annemarie.lang@charite.de.
Eric RöhnerDepartment of Orthopedics, Jena University Hospital, Campus Eisenberg, 07607 Eisenberg, Germany. e.roehner@krankenhaus-eisenberg.de.
Dörte HuscherDepartment of Rheumatology and Clinical Immunology, Charité University Hospital, 10117 Berlin, Germany. huscher@drfz.de.
Georg MatziolisDepartment of Orthopedics, Jena University Hospital, Campus Eisenberg, 07607 Eisenberg, Germany. g.matziolis@krankenhaus-eisenberg.de.
Gerd-Rüdiger BurmesterDepartment of Rheumatology and Clinical Immunology, Charité University Hospital, 10117 Berlin, Germany. gerd.burmester@charite.de.
Gerhard SchmidmaierDepartment of Orthopedics, University Hospital Heidelberg, 69118 Heidelberg, Germany. gerhard.schmidmaier@med.uni-heidelberg.de.
Carsten PerkaBerlin-Brandenburg Center for Regenerative Therapies (BCRT), 13353 Berlin, Germany. carsten.perka@charite.de.
Georg N DudaBerlin-Brandenburg Center for Regenerative Therapies (BCRT), 13353 Berlin, Germany. georg.duda@charite.de.
Frank ButtgereitDepartment of Rheumatology and Clinical Immunology, Charité University Hospital, 10117 Berlin, Germany. frank.buttgereit@charite.de.
German Rheumatism Research Centre · DEBerlin-Brandenburger Centrum für Regenerative Therapien · DEJena University Hospital · DEBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DEHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunologically restricted patients such as those with autoimmune diseases or malignancies often suffer from delayed or insufficient fracture healing. In human fracture hematomas and the surrounding bone marrow obtained from immunologically restricted patients, we analyzed the initial inflammatory phase on cellular and humoral level via flow cytometry and multiplex suspension array. Compared with controls, we demonstrated higher numbers of immune cells like monocytes/macrophages, natural killer T (NKT) cells, and activated T helper cells within the fracture hematomas and/or the surrounding bone marrow. Also, several pro-inflammatory cytokines such as Interleukin (IL)-6 and Tumor necrosis factor α (TNFα), chemokines (e.g., Eotaxin and RANTES), pro-angiogenic factors (e.g., IL-8 and Macrophage migration inhibitory factor: MIF), and regulatory cytokines (e.g., IL-10) were found at higher levels within the fracture hematomas and/or the surrounding bone marrow of immunologically restricted patients when compared to controls. We conclude here that the inflammatory activity on cellular and humoral levels at fracture sites of immunologically restricted patients considerably exceeds that of control patients. The initial inflammatory phase profoundly differs between these patient groups and is probably one of the reasons for prolonged or insufficient fracture healing often occurring within immunologically restricted patients.

Indexed as

Immunocompromised HostAngiogenesis Inducing AgentsBone MarrowCase-Control StudiesCytokinesFemaleFracture HealingFractures, BoneHematomaHematopoietic Stem CellsHumansInflammationInflammation MediatorsLeukocytesMaleNeovascularization, PhysiologicAngiogenesis Inducing AgentsCytokinesInflammation Mediatorsbone healingchemokinescytokinesfracture healingfracture hematomaimmune cellsimmunologically restricted patientsinflammation

Identifiers

PMID28282868
PMCPMC5372599
OpenAlexW2593443421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.